Global hidradenitis suppurativa COVID-19 registry: a registry to inform data-driven management practices

Naik, H. B., Alhusayen, R., Frew, J., Guilbault, S., Ingram, J. R. ORCID: https://orcid.org/0000-0002-5257-1142, Lowes, M. A., Marzano, A. V., Paul, M., Villumsen, B. and Yannuzzi, C. A. 2020. Global hidradenitis suppurativa COVID-19 registry: a registry to inform data-driven management practices. British Journal of Dermatology 183 (4) , pp. 780-781. 10.1111/bjd.19345

PDF - Accepted Post-Print Version Download (137kB)

Abstract

The management of hidradenitis suppurativa (HS), a chronic inflammatory skin disease, deserves special consideration in the context of the Coronavirus 2019 (COVID‐19) pandemic. A new Global Hidradenitis Suppurativa COVID‐19 Registry has been developed to capture data on risks, clinical course, and outcomes of COVID‐19 in HS patients. Caused by the virus SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus‐2), COVID‐19 is an easily transmissible disease which, in its most severe form, is characterized by respiratory failure and multiple organ dysfunction triggered by a cytokine storm response that predominates in older adults and those with significant comorbidities.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Wiley
ISSN:	0007-0963
Date of First Compliant Deposit:	16 July 2020
Date of Acceptance:	29 June 2020
Last Modified:	16 Nov 2024 13:45
URI:	https://orca.cardiff.ac.uk/id/eprint/133518

Citation Data

Cited 11 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item